Find Ranibizumab manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0INTERMEDIATES

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set

Listed Suppliers

read-more
read-more

01

LGM Pharma

U.S.A
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Flag U.S.A
Digital Content Digital Content

Ranibizumab

About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...

LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, analytical method development and testing, and commercial manufacturing. LGM Pharma offers custom API synthesis, analytical development, and regulatory services. With a network of over 300 accredited CGMP manufacturing partners, LGM provides unparalleled supply chain security. And, with over 100,000 square feet of FDA-inspected cGMP manufacturing and warehouse capacity, LGM Pharma provides a one-stop solution for solid dose, powder, semi-solid and liquid drugs.
LGM Pharma CB

02

Formnext Forum
Not Confirmed
arrow
arrow
Formnext Forum
Not Confirmed

Ranibizumab

About the Company : A leading biopharmaceutical company firstly developed the following products in China: rhG-CSF (filgrastim), Low Molecular Weight Heparin (LMWH, similar to dalteparin), Enoxaparin ...

A leading biopharmaceutical company firstly developed the following products in China: rhG-CSF (filgrastim), Low Molecular Weight Heparin (LMWH, similar to dalteparin), Enoxaparin sodium, Interleukin-eleven (oprelvekin), Palonosetron Hydrochloride, rhBMP-2 (recombinant human Bone Morphogenetic Protein-2). Our product pipeline include: Peg-Filgrastim, Recombinant Human Serum Albumin-Interferon α2b Fusion Protein, Exenatide, Fulvestrant, Ibandronate sodium, Aprepitant, Fosaprepitant and Goserelin. Our company is GMP certified. Both innovation and manufacturing oriented.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

read-more
read-more

01

Bioeq AG

Switzerland
Luxepack
Not Confirmed
arrow

Bioeq AG

Switzerland
arrow
Luxepack
Not Confirmed

Ranibizumab

Brand Name : Ranivisio

Dosage Form : Inj L?s

Dosage Strength : 2.3mg/0.23ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

02

Luxepack
Not Confirmed
arrow
arrow
Luxepack
Not Confirmed

Ranibizumab

Brand Name : Lucentis

Dosage Form : Inj L?s

Dosage Strength : 1.65mg/0.165ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

03

Luxepack
Not Confirmed
arrow
arrow
Luxepack
Not Confirmed

Ranibizumab

Brand Name : Lucentis

Dosage Form : Inj L?s

Dosage Strength : 2.3mg/0.23ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

04

Luxepack
Not Confirmed
arrow
arrow
Luxepack
Not Confirmed

Ranibizumab

Brand Name : Byooviz

Dosage Form : Inj Sol

Dosage Strength : 2.3mg/0.23ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Canada

read-more
read-more

01

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

RANIBIZUMAB

Brand Name : LUCENTIS

Dosage Form : SOLUTION

Dosage Strength : 10MG/ML

Packaging : 0.165ML

Approval Date :

Application Number : 2425629

Regulatory Info : Prescription

Registration Country : Canada

blank

02

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

RANIBIZUMAB

Brand Name : LUCENTIS

Dosage Form : SOLUTION

Dosage Strength : 10MG/ML

Packaging : 0.23ML

Approval Date :

Application Number : 2296810

Regulatory Info : Prescription

Registration Country : Canada

blank

03

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

RANIBIZUMAB

Brand Name : BYOOVIZ

Dosage Form : SOLUTION

Dosage Strength : 10MG/ML

Packaging :

Approval Date :

Application Number : 2525852

Regulatory Info : Prescription

Registration Country : Canada

blank

04

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

RANIBIZUMAB

Brand Name : RANOPTO

Dosage Form : SOLUTION

Dosage Strength : 10MG/ML

Packaging :

Approval Date :

Application Number : 2542250

Regulatory Info : Prescription

Registration Country : Canada

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

STOCK RECAP #PipelineProspector

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty